Antibodies against human NKG2D and uses thereof

The invention provides antibodies against human NKG2D and uses thereof, in particular to anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans and uses thereof. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANDERS SVENSSON, INGER LUND PEDERSEN, BIRGITTE URSOE, PETER ANDREAS REUMERT WAGTMANN
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ANDERS SVENSSON INGER LUND PEDERSEN BIRGITTE URSOE PETER ANDREAS REUMERT WAGTMANN
description	The invention provides antibodies against human NKG2D and uses thereof, in particular to anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans and uses thereof. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the antibodies when administered to a patient. Preferred antibodies include human monoclonal antibodies MS and 21 F2. As described herein, other antigen-binding molecules such as, e.g., antigen-binding antibody fragments, antibody derivatives, and multi-specific molecules, can be designed or derived from such antibodies.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN105001333A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN105001333A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN105001333A3</originalsourceid><addsrcrecordid>eNrjZNB3zCvJTMpPyUwtVkhMT8zMKy5RyCjNTcxT8PN2N3JRSMxLUSgtBkqWZKQWpean8TCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwNTAwNDY2NjR2Ni1AAAzp8p7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibodies against human NKG2D and uses thereof</title><source>esp@cenet</source><creator>ANDERS SVENSSON ; INGER LUND PEDERSEN ; BIRGITTE URSOE ; PETER ANDREAS REUMERT WAGTMANN</creator><creatorcontrib>ANDERS SVENSSON ; INGER LUND PEDERSEN ; BIRGITTE URSOE ; PETER ANDREAS REUMERT WAGTMANN</creatorcontrib><description>The invention provides antibodies against human NKG2D and uses thereof, in particular to anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans and uses thereof. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the antibodies when administered to a patient. Preferred antibodies include human monoclonal antibodies MS and 21 F2. As described herein, other antigen-binding molecules such as, e.g., antigen-binding antibody fragments, antibody derivatives, and multi-specific molecules, can be designed or derived from such antibodies.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151028&DB=EPODOC&CC=CN&NR=105001333A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151028&DB=EPODOC&CC=CN&NR=105001333A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANDERS SVENSSON</creatorcontrib><creatorcontrib>INGER LUND PEDERSEN</creatorcontrib><creatorcontrib>BIRGITTE URSOE</creatorcontrib><creatorcontrib>PETER ANDREAS REUMERT WAGTMANN</creatorcontrib><title>Antibodies against human NKG2D and uses thereof</title><description>The invention provides antibodies against human NKG2D and uses thereof, in particular to anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans and uses thereof. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the antibodies when administered to a patient. Preferred antibodies include human monoclonal antibodies MS and 21 F2. As described herein, other antigen-binding molecules such as, e.g., antigen-binding antibody fragments, antibody derivatives, and multi-specific molecules, can be designed or derived from such antibodies.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB3zCvJTMpPyUwtVkhMT8zMKy5RyCjNTcxT8PN2N3JRSMxLUSgtBkqWZKQWpean8TCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwNTAwNDY2NjR2Ni1AAAzp8p7g</recordid><startdate>20151028</startdate><enddate>20151028</enddate><creator>ANDERS SVENSSON</creator><creator>INGER LUND PEDERSEN</creator><creator>BIRGITTE URSOE</creator><creator>PETER ANDREAS REUMERT WAGTMANN</creator><scope>EVB</scope></search><sort><creationdate>20151028</creationdate><title>Antibodies against human NKG2D and uses thereof</title><author>ANDERS SVENSSON ; INGER LUND PEDERSEN ; BIRGITTE URSOE ; PETER ANDREAS REUMERT WAGTMANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN105001333A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANDERS SVENSSON</creatorcontrib><creatorcontrib>INGER LUND PEDERSEN</creatorcontrib><creatorcontrib>BIRGITTE URSOE</creatorcontrib><creatorcontrib>PETER ANDREAS REUMERT WAGTMANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANDERS SVENSSON</au><au>INGER LUND PEDERSEN</au><au>BIRGITTE URSOE</au><au>PETER ANDREAS REUMERT WAGTMANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibodies against human NKG2D and uses thereof</title><date>2015-10-28</date><risdate>2015</risdate><abstract>The invention provides antibodies against human NKG2D and uses thereof, in particular to anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans and uses thereof. Typically, the antibodies are fully human or humanized to minimize the risk for immune responses against the antibodies when administered to a patient. Preferred antibodies include human monoclonal antibodies MS and 21 F2. As described herein, other antigen-binding molecules such as, e.g., antigen-binding antibody fragments, antibody derivatives, and multi-specific molecules, can be designed or derived from such antibodies.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_CN105001333A
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Antibodies against human NKG2D and uses thereof
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A38%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANDERS%20SVENSSON&rft.date=2015-10-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN105001333A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true